{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T11:34:15Z","timestamp":1793100855532,"version":"4.5.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Overdose rates in the United States rose dramatically during the coronavirus disease 2019 (COVID-19) pandemic. Well-documented racial and sociodemographic inequities in the impact of the pandemic suggest the potential for similar inequities for overdose. Our objective was to identify subgroups of New York State Medicaid enrollees who experienced the greatest increases in nonfatal opioid overdose risk after the onset of the COVID-19 pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data are from a retrospective cohort of 1,021,889 people enrolled in New York State Medicaid from 2019 to 2020. To identify subgroups with the greatest increased risk of nonfatal overdose after the onset of the COVID-19 pandemic, we used a Heterogeneous Treatment Effect-Scan, a novel machine learning method developed for accurate and computationally efficient discovery of heterogeneous treatment effects in complex data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In the total sample, the risk of nonfatal opioid overdose increased 22% after the onset of the pandemic. We also identified two subgroups with elevated risk relative to the total sample: subgroup 1 (Black and Hispanic males aged 45\u201364 years old with no baseline documentation of opioid use disorder (OUD); N = 53,065) and subgroup 2 (people aged 45\u201364 years old with documented aged\/blind\/disabled status and no baseline documentation of OUD; N = 73,694). These subgroups experienced a 54% and 57% increase in nonfatal overdose risk, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We estimated heterogeneous effects of the onset of the COVID-19 pandemic on nonfatal overdose, with elevated risks estimated for older working-aged, structurally disadvantaged adults without documented OUD. These findings illustrate the importance of structural factors in driving heterogeneous risk of overdose after complex social events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ede.0000000000001992","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:00:08Z","timestamp":1776178808000},"page":"640-650","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Identifying Demographic Predictors of Increased Nonfatal Opioid Overdose Risk Among New York State Medicaid Enrollees After the COVID-19 Pandemic: An Analysis of Heterogeneous Treatment Effects"],"prefix":"10.1097","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0773-2349","authenticated-orcid":false,"given":"John R.","family":"Pamplin","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY"},{"name":"Department of Population Health, Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine, New York, NY"},{"name":"Machine Learning for Good Laboratory, Center for Urban Science and Progress, New York University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Wheeler-Martin","sequence":"additional","affiliation":[{"name":"Department of Population Health, Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Perry","sequence":"additional","affiliation":[{"name":"Department of Population Health, Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Mannes","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY"},{"name":"Department of Emergency Medicine, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Krawczyk","sequence":"additional","affiliation":[{"name":"Department of Population Health, Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[{"name":"Center for Health Services Research, Institute for Health, Rutgers University, New Brunswick, NJ"},{"name":"School of Social Work, Rutgers University, New Brunswick, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah S.","family":"Hasin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY"},{"name":"New York State Psychiatric Institute, New York, NY"},{"name":"Department of Psychiatry, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia S.","family":"Martins","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Shroff","sequence":"additional","affiliation":[{"name":"Machine Learning for Good Laboratory, Center for Urban Science and Progress, New York University, New York, NY"},{"name":"Department of Applied Statistics, Social Science, and Humanities, New York University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Cerd\u00e1","sequence":"additional","affiliation":[{"name":"Department of Population Health, Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine, New York, NY"},{"name":"Machine Learning for Good Laboratory, Center for Urban Science and Progress, New York University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Neill","sequence":"additional","affiliation":[{"name":"Department of Population Health, Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine, New York, NY"},{"name":"Machine Learning for Good Laboratory, Center for Urban Science and Progress, New York University, New York, NY"},{"name":"Department of Computer Science, Courant Institute of Mathematical Sciences, New York University, New York, NY"},{"name":"Robert F. Wagner Graduate School of Public Service, New York University, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"R1-20261027","doi-asserted-by":"crossref","first-page":"100S","DOI":"10.1177\/0033354920922975","article-title":"A rapid review of the impact of systems-level policies and interventions on population-level outcomes related to the opioid epidemic, United States and Canada, 2014-2018.","volume":"135","author":"Ansari","year":"2020","journal-title":"Public Health Rep"},{"key":"R2-20261027","first-page":"1","article-title":"Drug overdose deaths in the United States, 2003-2023.","volume":"522","author":"Garnett","year":"2024","journal-title":"NCHS Data Brief"},{"key":"R3-20261027","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","article-title":"Polysubstance use in the US opioid crisis.","volume":"26","author":"Compton","year":"2021","journal-title":"Mol Psychiatry"},{"key":"R4-20261027","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"R5-20261027","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2021.21040381","article-title":"Surging racial disparities in the US overdose crisis.","volume":"179","author":"Friedman","year":"2022","journal-title":"Am J Psychiatry"},{"key":"R6-20261027","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamapsychiatry.2022.0004","article-title":"Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic.","volume":"79","author":"Friedman","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"R7-20261027","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/aje\/kwab290","article-title":"Racial\/ethnic and geographic trends in combined stimulant\/opioid overdoses, 2007\u20132019.","volume":"191","author":"Townsend","year":"2022","journal-title":"Am J Epidemiol"},{"key":"R9-20261027","doi-asserted-by":"crossref","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","article-title":"Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics\u201425 states and the District of Columbia, 2019\u20132020.","volume":"71","author":"Kariisa","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R10-20261027","doi-asserted-by":"crossref","first-page":"e217112","DOI":"10.1001\/jamanetworkopen.2021.7112","article-title":"Trends in drug overdose mortality in Ohio during the first 7 months of the COVID-19 pandemic.","volume":"4","author":"Currie","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R11-20261027","doi-asserted-by":"crossref","first-page":"108176","DOI":"10.1016\/j.drugalcdep.2020.108176","article-title":"Signal of increased opioid overdose during COVID-19 from emergency medical services data.","volume":"214","author":"Slavova","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"R12-20261027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-021-00423-5","article-title":"The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data.","volume":"16","author":"Imtiaz","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"R15-20261027","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/jama.2020.17477","article-title":"Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic.","volume":"324","author":"Ochalek","year":"2020","journal-title":"JAMA"},{"key":"R16-20261027","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/jamapsychiatry.2020.4402","article-title":"Trends in US emergency department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic.","volume":"78","author":"Holland","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"R17-20261027","doi-asserted-by":"crossref","first-page":"109150","DOI":"10.1016\/j.drugalcdep.2021.109150","article-title":"Alcohol and other substance use during the COVID-19 pandemic: a systematic review.","volume":"229","author":"Roberts","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"R18-20261027","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","article-title":"Mental health, substance use, and suicidal ideation during the COVID-19 pandemic\u2014United States, June 24\u201330, 2020.","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R19-20261027","first-page":"222","article-title":"COVID-19-related changes to drug-selling networks and their effects on people who use illicit opioids.","volume":"84","author":"Frank","year":"2023","journal-title":"J Stud Alcohol Drugs"},{"key":"R20-20261027","doi-asserted-by":"crossref","first-page":"102958","DOI":"10.1016\/j.drugpo.2020.102958","article-title":"COVID-19 and the health of people who use drugs: what is and what could be?","volume":"83","author":"Grebely","year":"2020","journal-title":"Int J Drug Policy"},{"key":"R21-20261027","doi-asserted-by":"crossref","first-page":"103237","DOI":"10.1016\/j.drugpo.2021.103237","article-title":"Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada.","volume":"93","author":"Ali","year":"2021","journal-title":"Int J Drug Policy"},{"key":"R22-20261027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-020-00370-7","article-title":"Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic.","volume":"17","author":"Dunlop","year":"2020","journal-title":"Harm Reduct J"},{"key":"R23-20261027","doi-asserted-by":"crossref","first-page":"103140","DOI":"10.1016\/j.drugpo.2021.103140","article-title":"How will I get my next week\u2019s script? Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic.","volume":"92","author":"Krawczyk","year":"2021","journal-title":"Int J Drug Policy"},{"key":"R24-20261027","doi-asserted-by":"crossref","first-page":"108617","DOI":"10.1016\/j.drugalcdep.2021.108617","article-title":"Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder.","volume":"221","author":"Jacka","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"R25-20261027","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/j.pain.0000000000001950","article-title":"Considering the potential for an increase in chronic pain after the COVID-19 pandemic.","volume":"161","author":"Clauw","year":"2020","journal-title":"Pain"},{"key":"R27-20261027","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(20)30893-X","article-title":"COVID-19 exacerbating inequalities in the US.","volume":"395","author":"Dorn","year":"2020","journal-title":"Lancet"},{"key":"R28-20261027","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.15585\/mmwr.mm6942e1","article-title":"Race, ethnicity, and age trends in persons who died from COVID-19\u2014United States, May\u2013August 2020.","volume":"69","author":"Gold","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R29-20261027","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-6306","article-title":"Racial and ethnic disparities in COVID-19-Related infections, hospitalizations, and deaths: a systematic review.","volume":"174","author":"Mackey","year":"2021","journal-title":"Ann Intern Med"},{"key":"R30-20261027","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s10900-020-00920-x","article-title":"Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis.","volume":"45","author":"Noor","year":"2020","journal-title":"J Community Health"},{"key":"R31-20261027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2146","article-title":"Predictors of COVID-19 severity: a literature review.","volume":"31","author":"Gallo Marin","year":"2021","journal-title":"Rev Med Virol"},{"key":"R32-20261027","doi-asserted-by":"crossref","first-page":"e2110452","DOI":"10.1001\/jamanetworkopen.2021.10452","article-title":"Drug overdose deaths before and after shelter-in-place orders during the COVID-19 pandemic in San Francisco.","volume":"4","author":"Appa","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R33-20261027","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s11524-020-00484-0","article-title":"Impact of COVID-19 Pandemic on Drug Overdoses in Indianapolis.","volume":"97","author":"Glober","year":"2020","journal-title":"J Urban Health"},{"key":"R34-20261027","doi-asserted-by":"crossref","first-page":"e2125538","DOI":"10.1001\/jamanetworkopen.2021.25538","article-title":"Comparison of characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island.","volume":"4","author":"Macmadu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R35-20261027","doi-asserted-by":"crossref","first-page":"e2034878","DOI":"10.1001\/jamanetworkopen.2020.34878","article-title":"Racial\/ethnic disparities in unintentional fatal and nonfatal emergency medical services-attended opioid overdoses during the COVID-19 pandemic in Philadelphia.","volume":"4","author":"Khatri","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R36-20261027","doi-asserted-by":"crossref","first-page":"103127","DOI":"10.1016\/j.drugpo.2021.103127","article-title":"A rapid review of the impacts of Big Events on risks, harms, and service delivery among people who use drugs: implications for responding to COVID-19.","volume":"92","author":"Zolopa","year":"2021","journal-title":"Int J Drug Policy"},{"key":"R37-20261027","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugpo.2008.10.006","article-title":"Theorizing Big Events as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks.","volume":"20","author":"Friedman","year":"2009","journal-title":"Int J Drug Policy"},{"key":"R38-20261027","first-page":"rs.3.rs","article-title":"Social determinants of health and COVID-19 among patients in New York City.","author":"Baidal","year":"2020","journal-title":"Res Sq"},{"key":"R40-20261027","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/pm\/pnad121","article-title":"Evaluating chronic pain as a risk factor for COVID-19 complications among New York State Medicaid beneficiaries: a retrospective claims analysis.","volume":"24","author":"Perry","year":"2023","journal-title":"Pain Med"},{"key":"R41-20261027","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2010.05.017","article-title":"Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study.","volume":"112","author":"Edlund","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"R42-20261027","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MLR.0000000000000505","article-title":"A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain.","volume":"54","author":"Bohnert","year":"2016","journal-title":"Med Care"},{"key":"R43-20261027","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jpain.2019.01.003","article-title":"Eighteen-year trends in the prevalence of, and health care use for, noncancer pain in the United States: data from the medical expenditure panel survey.","volume":"20","author":"Nahin","year":"2019","journal-title":"J Pain"},{"key":"R44-20261027","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1136\/amiajnl-2013-001856","article-title":"Using electronic health records data to identify patients with chronic pain in a primary care setting.","volume":"20","author":"Tian","year":"2013","journal-title":"J Am Med Inform Assoc"},{"key":"R45-20261027","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1682\/JRRD.2014.10.0237","article-title":"Does comorbid chronic pain affect posttraumatic stress disorder diagnosis and treatment? Outcomes of posttraumatic stress disorder screening in department of veterans affairs primary care.","volume":"53","author":"Outcalt","year":"2016","journal-title":"J Rehabil Res Dev"},{"key":"R46-20261027","article-title":"Efficient discovery of heterogeneous treatment effects in randomized experiments via anomalous pattern detection.","author":"McFowland","year":"2018","journal-title":"arXiv preprint arXiv:1803.09159"},{"key":"R47-20261027","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/joim.13119","article-title":"Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States.","volume":"288","author":"Imam","year":"2020","journal-title":"J Intern Med"},{"key":"R48-20261027","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"R49-20261027","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.15585\/mmwr.mm6942e2","article-title":"Excess deaths associated with COVID-19, by age and race and ethnicity\u2014United States, January 26\u2013October 3, 2020.","volume":"69","author":"Rossen","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R50-20261027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.drugalcdep.2014.12.019","article-title":"Mortality among older adults with opioid use disorders in the Veteran\u2019s Health Administration, 2000-2011.","volume":"147","author":"Larney","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R51-20261027","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism.","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"R53-20261027","doi-asserted-by":"crossref","first-page":"e2142982","DOI":"10.1001\/jamanetworkopen.2021.42982","article-title":"Disparities by sex and race and ethnicity in death rates due to opioid overdose among adults 55 years or older, 1999 to 2019.","volume":"5","author":"Mason","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R55-20261027","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/add.15233","article-title":"African Americans now outpace whites in opioid\u2010involved overdose deaths: a comparison of temporal trends from 1999 to 2018.","volume":"116","author":"Furr\u2010Holden","year":"2020","journal-title":"Addiction"},{"key":"R56-20261027","doi-asserted-by":"crossref","first-page":"2050324520940428","DOI":"10.1177\/2050324520940428","article-title":"Exploring the impact of the opioid epidemic in Black and Hispanic communities in the United States.","volume":"6","author":"Drake","year":"2020","journal-title":"Drug Sci Policy Law"},{"key":"R57-20261027","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1377\/hlthaff.2023.00205","article-title":"Racial And ethnic disparities in buprenorphine receipt among Medicare beneficiaries, 2015-19.","volume":"42","author":"Miles","year":"2023","journal-title":"Health Aff (Millwood)"},{"key":"R58-20261027","doi-asserted-by":"crossref","first-page":"110963","DOI":"10.1016\/j.drugalcdep.2023.110963","article-title":"Racial\/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries.","volume":"252","author":"Miles","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"R59-20261027","doi-asserted-by":"crossref","first-page":"e1915638","DOI":"10.1001\/jamanetworkopen.2019.15638","article-title":"Association of disability with mortality from opioid overdose among US Medicare adults.","volume":"2","author":"Kuo","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R60-20261027","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.dhjo.2018.12.001","article-title":"Prescription opioid behaviors among adults with and without disabilities\u2014United States, 2015-2016.","volume":"12","author":"Lauer","year":"2019","journal-title":"Disabil Health J"},{"key":"R61-20261027","doi-asserted-by":"crossref","first-page":"e232052","DOI":"10.1001\/jamanetworkopen.2023.2052","article-title":"Quality of opioid use disorder treatment for persons with and without disabling conditions.","volume":"6","author":"Thomas","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R62-20261027","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/17441692.2021.1903528","article-title":"Big Events theory and measures may help explain emerging long-term effects of current crises.","volume":"16","author":"Friedman","year":"2021","journal-title":"Glob Public Health"},{"key":"R63-20261027","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1186\/s12889-025-24530-1","article-title":"Disparities in COVID-19 mortality in the United States, 2020-2023.","volume":"25","author":"Abidin","year":"2025","journal-title":"BMC Public Health"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/EDE.0000000000001992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T11:00:23Z","timestamp":1793098823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/EDE.0000000000001992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001992","relation":{},"ISSN":["1044-3983","1531-5487"],"issn-type":[{"value":"1044-3983","type":"print"},{"value":"1531-5487","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}